Yelak Biru discusses his experience in gathering information when he was diagnosed with multiple myeloma in 1995 versus the information landscape today, and addresses what he wishes he had known at the time.
Yelak Biru believes that a cancer diagnosis affects a person's entire family and support network, and notes that there are various ways for patients with cancer to involve and inform their families about their treatment.
Yelak Biru recalls being initially diagnosed with stage 3 multiple myeloma at age 25, and his subsequent relapse. Working with oncology teams, educating himself through support groups, and getting involved in associations as a speaker, Yelak has integrated myeloma into his life by becoming a patient advocate.
An in-depth overview of multiple myeloma and the unmet needs that patients with multiple myeloma face, as patient advocates from the US, Canada, and Europe assembled in Lisbon, Portugal for the first annual global Patient Leadership Council Multiple Myeloma Roundtable
Yelak Biru identifies similarities and differences between oral and physician-administered drugs, noting that patient-provider relationships are even more crucial when dealing with an oral drug regimen.
Last modified: December 15, 2017
Subscribe to CONQUER™: the patient voice™ magazine
Receive timely cancer news & updates, patient stories, and more.